HR6094-118

Introduced

To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to refine the set of information sources for determining coverage of certain drugs and biologicals used in the treatment or management of a rare disease or condition, and for other purposes.

118th Congress Introduced Oct 26, 2023

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to refine the set of information sources for determining coverage of certain drugs and biologicals used in the treatment or management of a rare disease or condition, and for other purposes., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Finance, Agriculture.

Who Benefits and How

health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section H6525F7570F6745259F0CA88AE97CF8AA: 1. Short title This Act may be cited as the Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act or the PROTECT Rare Act.
  • Section H13C13FF5D0C344289D334B99F1C46BB9: 2. Coverage of certain drugs used in treatment or management of rare disease or condition Section 1861(t)(2) of the Social Security Act (42 U.S.C. 1395x(t)(2))...
  • Section HE5E750E84E714DD5AE8F0FACD788839A: 2730. Expedited processes for review associated with certain drugs used in treatment or management of a rare disease or condition A group health plan or a...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.

At a Glance

What This Bill Does

This bill, To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to refine the set of information sources for determining coverage of certain drugs and biologicals used in the treatment or management of a rare disease or condition, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.

Key Policy Areas

Healthcare, Finance, Agriculture

Primary Purpose

This bill, To amend titles XVIII and XIX of the Social Security Act and title XXVII of the Public Health Service Act to refine the set of information sources for determining coverage of certain drugs and biologicals used in the treatment or management of a rare disease or condition, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.

Policy Domains

Healthcare Finance Agriculture

Whole bill

Identified Gains
Contextual inference, no direct clause citation
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • federal implementing agencies
  • health care providers and patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Legislative Progress

Introduced
Introduced Committee Passed
Oct 26, 2023

Ms. Matsui (for herself, Mr. Dunn of Florida, Mr. Thompson …

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Finance Agriculture
Actor Mappings
"federal_implementing_agencies"
→ Federal agencies assigned duties by the bill

Key Definitions

Terms defined in this bill

1 term
"medically accepted indication" §H13C13FF5D0C344289D334B99F1C46BB9

any use for a covered drug— which is approved under the Federal Food, Drug, and Cosmetic Act

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology